Derm In-Review

Home
United States
New York, NY
Derm In-Review

Derm In-Review is the #1 Board and MOC prep with the largest Q&A bank.

Over 10 yrs., Derm In-Review has prepared 11,500+ residents and 10,000 dermatologists. Derm IN-Review is a product of Our mission is to continue to provide quality educational resources that help prepare physicians for their career and beyond. We intend to continue to live up to that tradition by causing as little a disruption in services as possible. For over a decade, Derm In-Review has prepared more than 10,500 residents for the Board certifying exams, and has provided educational resources to more than 9,000 dermatology healthcare professionals.

01/16/2026

New Friday Pop Quiz just dropped! Can you pick the correct answer? Drop your best guess in the comments, then head to Next Steps in Derm (link in bio!) to see the correct choice and detailed explanations for the incorrect options. No peeking until you answer! 👀

https://ow.ly/8wjA50XXVE8

01/14/2026

The DIR x ODAC crossover event is almost upon us! 🙌

If you’re a dermatology resident headed to the ODAC Dermatology, Aesthetics & Surgical Conference this week, check out the following opportunities geared for you:
• Hands-On Aesthetic Skills Lab
• Three days of Board Review Workshops

Craft your schedule today by reviewing the ODAC agenda: https://ow.ly/HqMa50XWkx3.

Derm In-Review Advisory Council Co-Chairs Drs. Adam Friedman and Steven Daveluy will lecture on a variety of topics -- HS, GLP-1 agonists in dermatology, and more. Be sure to introduce yourself and say hello! 👋

01/09/2026

New Friday Pop Quiz is live! Can you guess the correct answer? Drop your best pick (A, B, C, D, or E) in the comments — then head to Next Steps in Derm (link below) to see the correct answer and explanations for the other choices. Good luck! 🧠👇

https://ow.ly/YUtK50XU1t0

01/07/2026

JAK inhibitors are quickly becoming key tools in pediatric dermatology, helping treat tough conditions like atopic dermatitis and alopecia areata in children. 🧒💊

A Next Steps in Derm session summary from the 2025 ODAC Dermatology, Aesthetics & Surgical Conference breaks down practical guidance:
✅ When to consider JAKs
✅ How to balance benefits vs. risks in growing kids
✅ Lab and safety monitoring
✅ Managing side effects like acne or cytopenias
✅ Navigating off-label use and insurance hurdles

For dermatologists and trainees, these real-world insights make it easier to integrate JAK therapy safely and thoughtfully into pediatric care. 🌟

Read the full summary: https://ow.ly/7aYa50XSrQY

01/02/2026

New Friday Pop Quiz is live! Think you know the answer? Drop your best choice in the comments, then head to Next Steps in Derm to see the correct answer and explanations.

Can you guess it right? https://ow.ly/HhrV50XR4pn

Image credit: https://dermnetnz.org/topics/nodulocystic-acne

12/30/2025

Dermatology residency isn’t just about clinical training — it’s the perfect time to build your voice in advocacy and leadership. 👩‍⚕️👨‍⚕️

Derm In-Review Advisory Council Member Dr. Courtney Hanna shares practical ways residents can influence the future of dermatology, both within and outside their institutions: https://ow.ly/CvrJ50XPTt9

You don’t have to wait until you’re an attending to get involved. Residency is your window to drive change, support your passions, and help shape a more equitable and effective specialty.

12/26/2025

Last Pop Quiz of 2025 — looking ahead to a sharper, stronger 2026! ✨

Friday Pop Quiz is live — can you guess the correct answer? Drop your best choice (A/B/C/D/E) in the comments, then head to Next Steps in Derm to see the correct answer and explanations for the other options. 📚✅

https://ow.ly/F5Sw50XOnOr

Don’t miss it — finish the year strong! 💪

12/23/2025

We would like to thank our sponsors, Sanofi Regeneron for their support of the Derm In-Review Digital Study Guide. The iconic exam prep guide is available in PDF format for on-the-go study, whenever, wherever. The digital study guide also includes a bonus chapter: CME In-Review! Download it today: https://ow.ly/v8WL50XNR46

Sanofi is a R&D driven, AI-powered biopharma company committed to improving people’s lives and creating compelling growth. Their team is guided by one purpose: to chase the miracles of science to improve people’s lives.

Regeneron, a leading biotechnology company, develops medicines for serious diseases. Founded by physician-scientists, their ability to translate science into medicine has led to numerous FDA-approved treatments and investigational candidates.

Learn More: www.regeneron.com

12/22/2025

Corticosteroids have long been the effective, accessible, and familiar backbone of dermatologic therapy — but with great power comes great responsibility. 🎧

In this episode, JDD Podcast Host Dr. Adam Friedman sits down with Dr. Alexandra Golant, chair of the new Corticosteroid Stewardship Consortium, to discuss what a modern reboot of steroid use really looks like.

They dive into steroid stewardship, tackling everything from mitigating misuse and addressing patient fears to redefining the role of corticosteroids amid today’s expanding landscape of biologics and small molecule inhibitors.

It’s a candid, timely conversation about keeping these invaluable tools both effective and safe for patients. Don’t miss it!

https://ow.ly/B0QX50XMZH5

12/19/2025

New Friday Pop Quiz is live! 🔍✨ Think you know the right answer? Drop your best choice (A/B/C/D/E) in the comments — no peeking! ⬇️ Then head over to Next Steps in Derm to see the correct answer and explanations for the other options: https://ow.ly/SNcQ50XMvVR

Good luck, residents! 💪

12/17/2025

Drug-induced hyperpigmentation is more common than many realize—accounting for up to 20% of acquired pigmentation cases. At the 2025 Pigmentary Disorders Exchange Symposium, Dr. Rebecca Vasquez delivered an expert walkthrough of how to recognize, diagnose, and differentiate these complex presentations from melasma or PIH.

From minocycline, antimalarials, and hydroquinone to less expected agents like silver and kratom, each drug leaves distinct clinical clues. Her key message: Not all hyperpigmentation is created equal. Recognizing drug-induced patterns leads to earlier diagnosis, better patient counseling, and more targeted management.

Read a Next Steps in Derm session summary: https://ow.ly/pgfk50XKvn7

12/12/2025

Friday Pop Quiz is live! 👩‍⚕️🧠 Can you pick the correct answer? Drop your best guess (A/B/C/D/E) in the comments👇 — then head to Next Steps in Derm to see the correct choice and full explanations for each option. Think you’ve got it? Prove it. 🔍✨

https://ow.ly/OlZl50XIw7M

Address

New York, NY

Telephone

(212) 213-5436

Website

http://dermatologyinreview.com/lilly/

Alerts

Be the first to know and let us send you an email when Derm In-Review posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Derm In-Review:

Shortcuts

Featured

Magnus Wellness
16 E 40th Street, Fl 4

Want your practice to be the top-listed Clinic in New York?